Medivir has announced that Yilmaz Mahshid leaves the position as CEO of Medivir.
The nomination committee proposes that he is elected as Board Member of the company and that Uli Hacksell is elected new Chairman of the Board.
Yilmaz Mahshid has tendered his resignation for personal reasons. Yilmaz Mahshid will remain as CEO until the Annual General Meeting 2021, which takes place on May 5, 2021.
The process of recruiting a new CEO has been initiated
“We thank Yilmaz Mahshid for his efforts as CEO. Important parts of Medivir’s transformational work has been carried out and an important financing has been completed during his leadership. It is very positive, and valuable for continuity, that he has accepted to be nominated for election to the Board of Directors at the upcoming Annual General Meeting,” says Medivir’s Chairman Helena Levander in a press release.
The process of recruiting a new CEO has been initiated. The board intends to appoint an interim CEO for the period from the Annual General Meeting until the new CEO is in place.
In addition, the committee will propose that Uli Hacksell, Lennart Hansson, An van Es Johansson and Bengt Westermark are re-elected as Board Members. Bengt Julander and Helena Levander have declined to be re-elected.